Table 3.
Substance use and substance-related problems as a function of source of nonmedical prescription opioids
Source | Binge drinking in the past 2 weeks
|
CAGE (+ screen) in the past year a |
Marijuana and other illicit drug use in the past month b |
DAST-10 (+ screen) in the past year c |
||||
---|---|---|---|---|---|---|---|---|
% | AOR d (95% CI) | % | AOR d (95% CI) | % | AOR d (95% CI) | % | AOR d (95% CI) | |
No nonmedical use (n=3859) | 50.2 | Ref | 18.3 | Ref | 16.1 | Ref | 5.7 | Ref |
Parent only (n=126) | 45.2 | 0.7 (0.46–1.06) | 16.7 | 0.8 (0.51–1.39) | 17.5 | 1.0 (0.63–1.72) | 7.9 | 1.3 (0.65–2.68) |
Peer only (n=259) | 82.6 | 4.4 (3.12–6.32)*** | 34.7 | 2.3 (1.67–3.05)*** | 52.7 | 5.7 (4.23–7.59)*** | 38.5 | 9.9 (7.20–13.68)*** |
Other sources (n=253) | 68.7 | 2.1 (1.58–2.87)*** | 32.1 | 2.1 (1.55–2.83)*** | 51.2 | 5.6 (4.20–7.53)*** | 39.7 | 11.3 (8.18–15.54)*** |
Ref=Reference group for each model was respondents who did not report nonmedical use of prescription opioids.
p<0.001.
A cutpoint score of two or more was used for the CAGE.
Consisted of any use of the following drugs in the past month: marijuana, cocaine, LSD, other psychedelics, ecstasy, inhalants, heroin or crystal methamphetamines.
A cutpoint score of three or more was used for the DAST-10.
Adjusted odds ratios (AOR) are adjusted for gender, race/ethnicity, class year and living arrangement (odds ratios for these variables are not shown).